| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 905 | 2022 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 576 | 2022 |
| Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study DW Eyre, SF Lumley, D O'Donnell, M Campbell, E Sims, E Lawson, ... elife 9, e60675, 2020 | 272 | 2020 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 268 | 2021 |
| T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study A Angyal, S Longet, SC Moore, RP Payne, A Harding, T Tipton, ... The Lancet Microbe 3 (1), e21-e31, 2022 | 188* | 2022 |
| The duration, dynamics, and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses in individual healthcare workers SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... Clinical Infectious Diseases 73 (3), e699-e709, 2021 | 159 | 2021 |
| Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Nature communications 12 (1), 5061, 2021 | 155 | 2021 |
| The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers SF Lumley, J Wei, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... MedRxiv, 2020.11. 02.20224824, 2020 | 143 | 2020 |
| Diagnostic accuracy of tests to detect Hepatitis C antibody: a meta-analysis and review of the literature W Tang, W Chen, A Amini, D Boeras, J Falconer, H Kelly, R Peeling, ... BMC infectious diseases 17, 39-57, 2017 | 133 | 2017 |
| Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis A Amini, O Varsaneux, H Kelly, W Tang, W Chen, DI Boeras, J Falconer, ... BMC infectious diseases 17, 19-37, 2017 | 122 | 2017 |
| Potent cross-reactive antibodies following Omicron breakthrough in vaccinees R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ... Cell 185 (12), 2116-2131. e18, 2022 | 116 | 2022 |
| T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses A Ogbe, B Kronsteiner, DT Skelly, M Pace, A Brown, E Adland, K Adair, ... Nature communications 12 (1), 2055, 2021 | 113 | 2021 |
| MAIT cell activation augments adenovirus vector vaccine immunogenicity NM Provine, A Amini, LC Garner, AJ Spencer, C Dold, C Hutchings, ... Science 371 (6528), 521-526, 2021 | 92 | 2021 |
| Human intestinal tissue-resident memory T cells comprise transcriptionally and functionally distinct subsets MEB FitzPatrick, NM Provine, LC Garner, K Powell, A Amini, SL Irwin, ... Cell reports 34 (3), 108661, 2021 | 63 | 2021 |
| Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern. DT Skelly, AC Harding, J Gilbert-Jaramillo, ML Knight, S Longet, A Brown, ... Research Square, 2021 | 52 | 2021 |
| Antibodies to SARS-CoV-2 are associated with protection against reinfection SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... MedRxiv, 2020.11. 18.20234369, 2020 | 50 | 2020 |
| Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients J Youngs, NM Provine, N Lim, HR Sharpe, A Amini, YL Chen, J Luo, ... PLoS Pathogens 17 (9), e1009804, 2021 | 44 | 2021 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ... Cell Reports, 111903, 2022 | 38 | 2022 |
| Further antibody escape by Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, J Huo, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... bioRxiv, 2022.05. 21.492554, 2022 | 32 | 2022 |
| MAIT cells in barrier tissues: lessons from immediate neighbors A Amini, D Pang, CP Hackstein, P Klenerman Frontiers in immunology 11, 584521, 2020 | 31 | 2020 |
